(R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin FunctionRajib Paul, Irving W. Wainer|Anesthesiology|2014Cited by 115
β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma CellsLawrence Toll, Irving W. Wainer|Journal of Pharmacology and Experimental Therapeutics|2010Cited by 39
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot studyAndrew McGarry, Ruin Moaddel, Cory Hackmyer et al.|Scientific Reports|2020Cited by 38
Cannabinoid Receptor Activation Correlates with the Proapoptotic Action of the β2-Adrenergic Agonist (R,R′)-4-Methoxy-1-Naphthylfenoterol in HepG2 Hepatocarcinoma CellsRajib Paul, Irving W. Wainer|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 19
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonistArtur Wnorowski, Irving W. Wainer|Scientific Reports|2022Cited by 12